{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:09:30Z","timestamp":1792807770018,"version":"4.5.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0205251","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T13:29:18Z","timestamp":1539350958000},"page":"e0205251","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-4760","authenticated-orcid":true,"given":"Fabio","family":"Zugni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ruju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Pricolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Iorfida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Angelo","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Bellomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Petralia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"ref1","unstructured":"Breast cancer survival statistics | Cancer Research UK [Internet]. [cited 2017 May 13]. Available from: http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer\/survival#heading-Three<\/ext-link>"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.breast.2016.10.005","article-title":"Improved survival in metastatic breast cancer 1985\u20132016","volume":"31","author":"M Sundquist","year":"2017","journal-title":"The Breast"},{"key":"ref3","year":"2009"},{"issue":"20","key":"ref4","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity","volume":"12","author":"RE Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"20","key":"ref5","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic Behavior of Breast Cancer Subtypes","volume":"28","author":"H Kennecke","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref6","article-title":"Title: Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases","author":"J-J Body","year":"2017","journal-title":"Crit Rev Oncol"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2354.2009.01135.x","article-title":"The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain","volume":"19","author":"RD POCKETT","year":"2010","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref8","article-title":"3rd ESO\u2013ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)","author":"F Cardoso","year":"2016","journal-title":"The Breast"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bjc.6605546","article-title":"Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer","volume":"102","author":"T Hamaoka","year":"2010","journal-title":"Br J Cancer"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.breast.2013.03.006","article-title":"International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)\u2013MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer","volume":"22","author":"NU Lin","year":"2013","journal-title":"The Breast"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/RLU.0000000000001820","article-title":"89Zr-Trastuzumab PET\/CT for Detection of Human Epidermal Growth Factor Receptor 2\u2013Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2\u2013Negative Primary Breast Cancer","volume":"42","author":"GA Ulaner","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2967\/jnumed.116.183335","article-title":"Prospective Clinical Trial of 18<\/sup> F-Fluciclovine PET\/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers","volume":"58","author":"GA Ulaner","year":"2017","journal-title":"J Nucl Med"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2967\/jnumed.115.170456","article-title":"Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET\/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers","volume":"57","author":"GA Ulaner","year":"2016","journal-title":"J Nucl Med"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41824-017-0019-6","article-title":"Trends in oncologic hybrid imaging","volume":"2","author":"AG Wibmer","year":"2018","journal-title":"Eur J hybrid imaging"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3892\/ijo.2017.4012","article-title":"Staging performance of whole-body DWI, PET\/CT and PET\/MRI in invasive ductal carcinoma of the breast","volume":"51","author":"OA Catalano","year":"2017","journal-title":"Int J Oncol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-017-3849-3","article-title":"Integrated 18F-FDG PET\/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy","volume":"45","author":"N Cho","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"ref18","first-page":"275","article-title":"Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display","volume":"22","author":"T Takahara","year":"2017","journal-title":"Radiat Med"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejrad.2009.03.054","article-title":"Whole-body diffusion-weighted magnetic resonance imaging","volume":"70","author":"TC Kwee","year":"2009","journal-title":"Eur J Radiol"},{"issue":"1A","key":"ref20","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1102\/1470-7330.2011.9034","article-title":"Bony metastases: assessing response to therapy with whole-body diffusion MRI","author":"AR Padhani","year":"2011","journal-title":"Cancer Imaging"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/jmri.24548","article-title":"Therapy monitoring of skeletal metastases with whole-body diffusion MRI","volume":"39","author":"AR Padhani","year":"2014","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.seminoncol.2010.11.007","article-title":"The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer","volume":"38","author":"TE Yankeelov","year":"2011","journal-title":"Semin Oncol"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"e79008","DOI":"10.1371\/journal.pone.0079008","article-title":"The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis","volume":"8","author":"L Chen","year":"2013","journal-title":"PLoS One"},{"issue":"17","key":"ref24","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1158\/0008-5472.CAN-13-3534","article-title":"Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging","volume":"74","author":"NS White","year":"2014","journal-title":"Cancer Res"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.2214\/AJR.08.2093","article-title":"Pitfalls in Abdominal Diffusion-Weighted Imaging: How Predictive is Restricted Water Diffusion for Malignancy","volume":"193","author":"S Feuerlein","year":"2009","journal-title":"Am J Roentgenol"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"W336","DOI":"10.2214\/AJR.17.17984","article-title":"Whole-Body MRI: Current Applications in Oncology","volume":"209","author":"M Morone","year":"2017","journal-title":"Am J Roentgenol"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","article-title":"Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement","volume":"33","author":"MA Dimopoulos","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","article-title":"Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications","volume":"25","author":"R Walker","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref29","first-page":"1","article-title":"METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer","author":"AR Padhani","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/RLU.0b013e31815f23b7","article-title":"Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer","volume":"33","author":"P Shie","year":"2008","journal-title":"Clin Nucl Med"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","article-title":"Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy","volume":"21","author":"H-L Yang","year":"2011","journal-title":"Eur Radiol"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00330-013-3083-8","article-title":"Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET\/CT","volume":"24","author":"K Michielsen","year":"2014","journal-title":"Eur Radiol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00330-007-0732-9","article-title":"Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging","volume":"18","author":"S Fujii","year":"2008","journal-title":"Eur Radiol"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10549-012-2160-z","article-title":"Menke-Pluymers MBE, et al. Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences","volume":"135","author":"ABG Kwast","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1148\/radiol.2232011081","article-title":"Peritoneal Metastases: Detection with Spiral CT in Patients with Ovarian Cance","volume":"223","author":"F V Coakley","year":"2002","journal-title":"Radiology"},{"issue":"S1","key":"ref36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1525-1438.2006.00471.x","article-title":"Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer","volume":"16","author":"M MURAKAMI","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4297\/najms.2011.3227","article-title":"E-Cadherin as a diagnostic biomarker in breast cancer","volume":"3","author":"R Singhai","year":"2011","journal-title":"N Am J Med Sci"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1309\/JMRD-W08Y-6K8M-7AD8","article-title":"Does the Level of E-Cadherin Expression Correlate With the Primary Breast Carcinoma Infiltration Pattern and Type of Systemic Metastases?","volume":"118","author":"NS Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.2349\/biij.2.4.e59","article-title":"Physiological uptake in FDG PET simulating disease","volume":"2","author":"S Ahmad Sarji","year":"2006","journal-title":"Biomed Imaging Interv J"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1148\/rg.271065080","article-title":"Bowel Hot Spots at PET-CT","volume":"27","author":"HB Prabhakar","year":"2007","journal-title":"RadioGraphics"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.2002.20.2.379","article-title":"Biologic Correlates of 18<\/sup> Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography","volume":"20","author":"R Bos","year":"2002","journal-title":"J Clin Oncol"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s00259-015-3080-z","article-title":"Appearance of untreated bone metastases from breast cancer on FDG PET\/CT: importance of histologic subtype","volume":"42","author":"BZ Dashevsky","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1148\/radiol.2461061907","article-title":"Nodal Metastasis in Non\u2013Small Cell Lung Cancer: Accuracy of 3.0-T MR Imaging","volume":"246","author":"HY Kim","year":"2008","journal-title":"Radiology"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.rli.0000185878.61270.b0","article-title":"High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system","volume":"40","author":"GP Schmidt","year":"2005","journal-title":"Invest Radiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejca.2017.03.001","article-title":"The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer","volume":"77","author":"M Kosmin","year":"2017","journal-title":"Eur J Cancer"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"CI Li","year":"2005","journal-title":"Br J Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0205251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:45:47Z","timestamp":1589028347000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0205251"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,12]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0205251","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,12]]}}}